These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 8841635)
21. Inhibition of human T-cell leukemia virus type 1 replication by antisense env oligodeoxynucleotide. Maeda N; Kawamura T; Hoshino H; Yamada N; Blackard J; Kushida S; Miyano-Kurosaki N; Yamamoto N; Makino K; Yokota T; Uchida K; Miwa M Biochem Biophys Res Commun; 1998 Feb; 243(1):109-12. PubMed ID: 9473488 [TBL] [Abstract][Full Text] [Related]
22. Antisense inhibitory effect: a comparison between 3'-partial and full phosphorothioate antisense oligonucleotides. Galderisi U; Di Bernardo G; Melone MA; Galano G; Cascino A; Giordano A; Cipollaro M J Cell Biochem; 1999 Jul; 74(1):31-7. PubMed ID: 10381259 [TBL] [Abstract][Full Text] [Related]
23. Specific block of androgen receptor activity by antisense oligonucleotides. Hamy F; Brondani V; Spoerri R; Rigo S; Stamm C; Klimkait T Prostate Cancer Prostatic Dis; 2003; 6(1):27-33. PubMed ID: 12664061 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of collagenase type I expression by psoralen antisense oligonucleotides in dermal fibroblasts. Lin M; Hultquist KL; Oh DH; Bauer EA; Hoeffler WK FASEB J; 1995 Oct; 9(13):1371-7. PubMed ID: 7557028 [TBL] [Abstract][Full Text] [Related]
25. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells. Hatta T; Takai K; Nakada S; Yokota T; Takaku H Biochem Biophys Res Commun; 1997 Mar; 232(2):545-9. PubMed ID: 9125219 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of HIV-1 replication by a new type of circular dumbbell RNA/DNA chimeric oligonucleotides. Park WS; Miyano-Kurosaki N; Abe T; Takai K; Yamamoto N; Takaku H Biochem Biophys Res Commun; 2000 Apr; 270(3):953-60. PubMed ID: 10772932 [TBL] [Abstract][Full Text] [Related]
27. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines. Janicek MF; Angioli R; Unal AD; Sevin BU; Madrigal M; Estape R; Averette HE Gynecol Oncol; 1997 Jul; 66(1):94-102. PubMed ID: 9234928 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and anti-influenza virus-A activity of circular dumbbell RNA DNA chimeric oligonucleotides. Abe T; Hatta T; Yamakawa H; Takai K; Yokota T; Takaku H Nucleic Acids Symp Ser; 1997; (37):219-20. PubMed ID: 9586078 [TBL] [Abstract][Full Text] [Related]
29. An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells. Peng J; He X; Wang K; Tan W; Li H; Xing X; Wang Y Nanomedicine; 2006 Jun; 2(2):113-20. PubMed ID: 17292123 [TBL] [Abstract][Full Text] [Related]
32. In situ high-resolution transmission electron microscopy of photocatalytic reactions by excited electrons in ionic liquid. Yoshida K; Nozaki T; Hirayama T; Tanaka N J Electron Microsc (Tokyo); 2007 Oct; 56(5):177-80. PubMed ID: 17947794 [TBL] [Abstract][Full Text] [Related]
33. Synthesis of antisense oligodeoxyribonucleotides and their anti-HIV activity. Gug-Kim S; Suzuki Y; Nakashima H; Yamamoto N; Takaku H Nucleic Acids Symp Ser; 1991; (25):103-4. PubMed ID: 1842040 [No Abstract] [Full Text] [Related]
34. Photodynamic antisense regulation of human cervical carcinoma cell growth using psoralen-conjugated oligo(nucleoside phosphorothioate). Murakami A; Yamayoshi A; Iwase R; Nishida J; Yamaoka T; Wake N Eur J Pharm Sci; 2001 Apr; 13(1):25-34. PubMed ID: 11292565 [TBL] [Abstract][Full Text] [Related]
35. Antisense DNA-analogs. Inhibition of human immunodeficiency virus. Ebright Y; Raska K; Gaur S; Frenkel L; Tsao J; Stein S N J Med; 1990 Dec; 87(12):1011-5. PubMed ID: 2270148 [No Abstract] [Full Text] [Related]
36. Synthesis of Nucleobase-Functionalized Morpholino Monomers. Nandi B; Pattanayak S; Paul S; Kundu J; Sinha S Methods Mol Biol; 2019; 1973():107-130. PubMed ID: 31016698 [TBL] [Abstract][Full Text] [Related]
37. A simple method for delivering morpholino antisense oligos into the cytoplasm of cells. Partridge M; Vincent A; Matthews P; Puma J; Stein D; Summerton J Antisense Nucleic Acid Drug Dev; 1996; 6(3):169-75. PubMed ID: 8915501 [TBL] [Abstract][Full Text] [Related]
38. Use of partially phosphorothioated "antisense" oligodeoxynucleotides for sequence-dependent modulation of hematopoiesis in culture. Ehrlich G; Patinkin D; Ginzberg D; Zakut H; Eckstein F; Soreq H Antisense Res Dev; 1994; 4(3):173-83. PubMed ID: 7849488 [TBL] [Abstract][Full Text] [Related]
39. Oligonucleotide conjugates as potential antisense drugs with improved uptake, biodistribution, targeted delivery, and mechanism of action. Manoharan M Antisense Nucleic Acid Drug Dev; 2002 Apr; 12(2):103-28. PubMed ID: 12074364 [TBL] [Abstract][Full Text] [Related]
40. Rational design and rapid screening of antisense oligonucleotides for prokaryotic gene modulation. Shao Y; Wu Y; Chan CY; McDonough K; Ding Y Nucleic Acids Res; 2006; 34(19):5660-9. PubMed ID: 17038332 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]